Rezolute (RZLT) Long-Term Debt Issuances (2012 - 2018)

Rezolute (RZLT) reported Long-Term Debt Issuances of $4.1 million for Q2 2018, up 491.43% sequentially from $700000.0 in Q1 2018.

Rezolute (RZLT) Long-Term Debt Issuances (2012 - 2018) Analysis & Trends

Rezolute (RZLT) has 4 years of Long-Term Debt Issuances data on file, last reported at $4.1 million in Q2 2018.

For the quarter ending Q2 2018, Long-Term Debt Issuances changed N/A year-over-year to $4.1 million; the trailing twelve-month figure through Jun 2019 stood at $4.8 million (changed 0.0% YoY), and the FY2022 full-year result was $16.0 million, up 6.75% from the prior year.
Long-Term Debt Issuances climbed to $4.1 million in Q2 2018, from $700000.0 in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $4.1 million in Q2 2018 to a low of -$1.2 million in Q1 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Rezolute	31,153.77	31,153.77	-	-

Download Data